0001564590-19-002593 Sample Contracts

Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab
Option and License Agreement • February 12th, 2019 • Dermira, Inc. • Pharmaceutical preparations

- Almirall acquires option to license rights to develop and commercialize lebrikizumab for atopic dermatitis in Europe

Sample 1
AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!